RedHill Biopharma (RDHL) FCF Margin (QoQ) (2012 - 2022)
RedHill Biopharma (RDHL) FCF Margin (QoQ) (2012 - 2022) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1,530.00 |
| Sep 30, 2022 | 5,527.00 |
| Jun 30, 2022 | -5,788.00 |
| Mar 31, 2022 | 3,570.00 |
| Dec 31, 2021 | 2,063.00 |
| Sep 30, 2021 | -7.00 |
| Jun 30, 2021 | -2,868.00 |
| Mar 31, 2021 | -22.00 |
| Dec 31, 2020 | -1,597.00 |
| Sep 30, 2020 | 2,882.00 |
| Jun 30, 2020 | 91,133.00 |
| Mar 31, 2020 | -11,296.00 |
| Dec 31, 2019 | -23,543.00 |
| Sep 30, 2019 | 2,583.00 |
| Jun 30, 2019 | -22,726.00 |
| Mar 31, 2019 | 16,924.00 |
| Dec 31, 2018 | -22,320.00 |
| Sep 30, 2018 | -2,206.00 |
| Jun 30, 2018 | 3,053.00 |
| Mar 31, 2018 | 31,994.00 |